ArticleBMB reports2023

Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways.

Sung-Hoon Lee et al.PubMed ↗Full text ↗

No numbers read from the abstract.